Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 September 2005 to 30 September 2005 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC [1] or Article 38 of Directive 2001/82/EC [2]) (2005/C 268/03) Issuing, maintenance or modification of a national marketing authorisation Date of the decision | Name(s) of the medicinal product | Holder(s) of the marketing authorization | Member State concerned | Date of notification | 15.9.2005 | Lansopon | See Annex I | See Annex I | 19.9.2005 | 15.9.2005 | Lansoprazol HEXAL | See Annex II | See Annex II | 19.9.2005 | [1] OJ L 311, 28.11.2001, p. 67. [2] OJ L 311, 28.11.2001, p. 1. -------------------------------------------------- ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, APPLICANT, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES Member State | Marketing authorisation holder | Applicant | Invented name | Strength | Pharmaceutical form | Route of administration | Belgium | — | HEXAL AG Industriestraße 25 DE-83607 Holzkirchen | Lansoprazole BEXAL 15 mg gélules gastro-resistantes | 15 mg | Gastro-resistant capsule, hard | Oral use | Lansoprazole BEXAL 30 mg gélules gastro-resistantes | 30 mg | Gastro-resistant capsule, hard | Oral use | Lansoprazol HEXAL | 30 mg | Gastro-resistant capsule, hard | Oral use | Germany | — | HEXAL AG Industriestraße 25 DE-83607 Holzkirchen | Lansoprazol HEXAL 15 mg Hartkapseln | 15 mg | Gastro-resistant capsule, hard | Oral use | Lansoprazol HEXAL 30 mg Hartkapseln | 30 mg | Gastro-resistant capsule, hard | Oral use | Finland | HEXAL AG Industriestraße 25 DE-83607 Holzkirchen | — | Lansopon 15mg | 15 mg | Gastro-resistant capsule, hard | Oral use | Lansopon 30 mg | 30 mg | Gastro-resistant capsule, hard | Oral use | Luxembourg | — | HEXAL AG Industriestraße 25 DE-83607 Holzkirchen | Lansoprazol HEXAL 15 mg Hartkapseln | 15 mg | Gastro-resistant capsule, hard | Oral use | Lansoprazol HEXAL 30 mg Hartkapseln | 30 mg | Gastro-resistant capsule, hard | Oral use | -------------------------------------------------- ANNEX II LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, APPLICANT, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES Member State | Marketing authorisation holder | Applicant | Invented name | Strength | Pharmaceutical form | Route of administration | Austria | — | HEXAL AG Industriestraße 25 DE-83607 Holzkirchen | Lansohexal 15 mg — Hartkapseln | 15 mg | Gastro-resistant capsule, hard | Oral use | Lansohexal 30 mg — Hartkapseln | 30 mg | Gastro-resistant capsule, hard | Oral use | Denmark | — | HEXAL AG Industriestraße 25 DE-83607 Holzkirchen | Lansoprazol HEXAL | 15 mg | Gastro-resistant capsule, hard | Oral use | Lansoprazol HEXAL | 30 mg | Gastro-resistant capsule, hard | Oral use | Germany | — | HEXAL AG Industriestraße 25 DE-83607 Holzkirchen | Lansohexal 15 mg Hartkapseln | 15 mg | Gastro-resistant capsule, hard | Oral use | Lansohexal 30 mg Hartkapseln | 30 mg | Gastro-resistant capsule, hard | Oral use | Finland | HEXAL AG Industriestraße 25 DE-83607 Holzkirchen | — | Lansoprazol HEXAL 15mg | 15 mg | Gastro-resistant capsule, hard | Oral use | Lansoprazol HEXAL 30 mg | 30 mg | Gastro-resistant capsule, hard | Oral use | Sweden | — | HEXAL AG Industriestraße 25 DE-83607 Holzkirchen | Lansocid | 15 mg | Gastro-resistant capsule, hard | Oral use | Lansocid | 30 mg | Gastro-resistant capsule, hard | Oral use | --------------------------------------------------
